Centennial Wealth Advisory’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$348K Buy
2,396
+598
+33% +$82.6K 0.07% 145
2026
Q2
$231K Sell
1,798
-139
-7% -$16.3K 0.05% 169
2026
Q1
$233K Sell
1,937
-221
-10% -$25.5K 0.06% 146
2025
Q4
$227K Buy
+2,158
New +$203K 0.06% 152
2025
Q2
– Sell
-5,254
Closed -$472K – 164
2025
Q1
$472K Buy
5,254
+402
+8% +$37.5K 0.17% 84
2024
Q4
$483K Buy
4,852
+526
+12% +$54.2K 0.19% 67
2024
Q3
$491K Buy
4,326
+340
+9% +$40.4K 0.19% 61
2024
Q2
$494K Sell
3,986
-424
-10% -$54.6K 0.21% 61
2024
Q1
$582K Buy
4,410
+75
+2% +$9.24K 0.27% 52
2023
Q4
$473K Buy
+4,335
New +$450K 0.24% 63
2023
Q2
– Sell
-5,465
Closed -$581K – 136
2023
Q1
$581K Buy
5,465
+1,653
+43% +$178K 0.31% 52
2022
Q4
$423K Buy
3,812
+198
+5% +$20.2K 0.24% 61
2022
Q3
$311K Buy
+3,614
New +$323K 0.18% 65

Other funds holding MRK

Centennial Wealth Advisory's MRK Position: Q3 2026 in Review

Centennial Wealth Advisory increased its Merck (MRK) stake by 33% in Q3 2026, buying an estimated $82.6K and bringing the position to 2,396 shares worth $348K. The position accounts for 0.07% of the portfolio, ranked #145.

Centennial Wealth Advisory first reported a position in MRK in Q3 2022 and has held it in 13 quarters since. The position peaked at $582K in Q1 2024. 2,434 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Centennial Wealth Advisory held 2,396 shares of Merck worth $348K as of Q3 2026.
  • Centennial Wealth Advisory bought 598 Merck shares in Q3 2026, an estimated $82.6K.
  • Merck made up 0.07% of Centennial Wealth Advisory's portfolio in Q3 2026, its #145 holding.
  • Centennial Wealth Advisory first reported a position in Merck in Q3 2022 and has held it in 13 quarters since.
  • Centennial Wealth Advisory's Merck position peaked at $582K in Q1 2024.
  • 2,434 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Centennial Wealth Advisory's 13F filing for Q3 2026, filed 16 Oct 2026.